FierceBiotechOriginal article
{"a":[{"_":"Guardant wins FDA nod for diagnostic guiding use of AstraZeneca’s Etcamah","$":{"href":"/medtech/guardant-nabs-fda-approval-diagnostic-seeking-out-patients-astrazenecas-new-cancer-med","hreflang":"en"}}]}
RegulatoryapprovedEtcamahPositive
AI Analysis
Summary
Guardant Health received FDA approval for its companion diagnostic to guide the use of AstraZeneca's breast cancer drug Etcamah. The approval follows the recent authorization of Etcamah itself.
Outcome Details
FDA approval of Guardant companion diagnostic for AstraZeneca's Etcamah
Importance:7/10
Sentiment:
0.80
FDA approvalcompanion diagnosticbreast cancerregulatory
Read the original article
Published by FierceBiotech on September 7, 2026 2:09 AM